Analysis of gastric atrophy induced by Helicobacter pylori (H. pylori) infection using serum anti-Helicobacter pylori antibody, anti-Caga antibody, and pepsinogen status

被引：0
|
作者：
Yamaji, Y
Shibata, W
Watabe, H
Yanai, A
Hirata, Y
Mitsuno, Y
Maeda, S
Yoshida, H
Kawabe, T
Omata, M
机构：
来源：
GASTROENTEROLOGY | 2003年 / 124卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(03)82142-X
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A424 / A424
页数：1
相关论文
共 50 条
  • [1] Serum Anti-Helicobacter pylori IgG Antibody Titer in H. pylori-negative Cases with a Different Gastric Mucosal Atrophy Status
    Adachi, Kyoichi
    Kishi, Kanako
    Notsu, Takumi
    Mishiro, Tomoko
    Sota, Kazunari
    Ishimura, Norihisa
    Ishihara, Shunji
    INTERNAL MEDICINE, 2020, 59 (22) : 2817 - 2823
  • [2] Short half-life of serum anti-CagA antibody:: Comparison with conventional anti-Helicobacter pylori antibody.
    Yoshida, H
    Maeda, S
    Ogura, K
    Kawaguchi, R
    Ikenoue, T
    Kanai, F
    Kawabe, T
    Shiratori, Y
    Omata, M
    GASTROENTEROLOGY, 1998, 114 (04) : A342 - A342
  • [3] Incidence of anti-Helicobacter pylori and anti-CagA antibodies in rosacea patients
    Argenziano, G
    Donnarumma, G
    Iovene, MR
    Arnese, P
    Baldassarre, MA
    Baroni, A
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2003, 42 (08) : 601 - 604
  • [4] Effect of anti-Helicobacter pylori IgG antibody titer following eradication of Helicobacter pylori infection
    Koizumi, W
    Tanabe, S
    Imaizumi, H
    Hibi, K
    Kida, M
    Ohida, M
    Okayasu, I
    Saigenji, K
    HEPATO-GASTROENTEROLOGY, 2003, 50 (49) : 293 - 296
  • [5] Anti-Helicobacter pylori IgG antibody: Usefulness in testing Helicobacter pylori eradication
    Kojimahara, N
    Nemoto, Y
    Taniai, M
    Mitsunaga, A
    Hayashi, N
    Obata, H
    GASTROENTEROLOGY, 1997, 112 (04) : A179 - A179
  • [6] Anti-Helicobacter pylori antibody IgG and IgA and toxinogenicity of Helicobacter pylori.
    Zhang, QB
    Etolhi, G
    Dawodu, JB
    Nakshabendi, IM
    Mokhashi, MS
    Russell, RI
    Gemmell, CG
    GASTROENTEROLOGY, 1997, 112 (04) : A1127 - A1127
  • [7] Serum anti-Helicobacter pylori antibody titer and endoscopic findings as predictors of gastric cancer and H. pylori infection: A cross-sectional study
    Toyoshima, Osamu
    Nishizawa, Toshihiro
    Sakitani, Kosuke
    Yamakawa, Tadahiro
    Hata, Keisuke
    Watanabe, Hidenobu
    Suzuki, Hidekazu
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 362 - 362
  • [8] Usefulness of anti-Helicobacter pylori and anti-CagA antibodies in the selection of patients for gastroscopy
    Heikkinen, M
    Janatuinen, E
    Mayo, K
    Megraud, F
    Julkunen, R
    Pikkarainen, P
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 1997, 92 (12): : 2225 - 2229
  • [9] Anti-CagA antibodies in dyspeptic patients with no Helicobacter pylori infection
    Toro, C
    Alvarez, P
    Casado, I
    Carbó, J
    Samaniego, J
    Iñiguez, A
    Alonso, MJ
    Baquero, M
    GUT, 1999, 45 : A8 - A8
  • [10] Inhibition of Helicobacter pylori infection by orally administered yolk-derived anti-Helicobacter pylori antibody
    Shimamoto, C
    Tokioka, S
    Hirata, I
    Tani, H
    Ohishi, H
    Katsu, K
    HEPATO-GASTROENTEROLOGY, 2002, 49 (45) : 709 - 714
12345